参考文献/References:
[1]Maraki S,Mantadakis E,Nioti E,et al.Susceptibility of 2252 Pseudomonas aeruginosa Clinical Isolates Over 4 Years to 9 Antimicrobials in a Tertiary Greek Hospital[J].Chemotherapy,2014,60(5-6):334-341.
[2]胡付品,郭燕,朱德妹,等.2017年CHINET中国细菌耐药性监测[J].中国感染与化疗杂志,2018,18(3):241-251.
[3]王启,季萍,徐修礼,等.2016年中国14家教学医院革兰阴性杆菌耐药监测分析[J].中华检验医学杂志,2017,40(8):614-622.
[4]张祎博,孙景勇,倪语星,等.2005~2014年CHINET铜绿假单胞菌耐药性监测[J].中国感染与化疗杂志,2016,16(2):141-145.
[5]赵祝香,周泉,陈惠玲,等.2011~2016年铜绿假单胞菌耐药性变迁分析[J].广州医药,2018,49(3):55-58.
[6]陈宏斌,赵春江,王辉,等.2011年中国13家教学医院院内感染常见病原菌耐药性分析[J].中华内科杂志,2013,52(3):203-212.
相似文献/References:
[1]李绪定.碳青霉烯类治疗铜绿假单胞菌肺炎的临床效果分析[J].医学信息,2018,31(13):134.[doi:10.3969/j.issn.1006-1959.2018.13.039]
LI Xu-ding.Clinical Effect of Carbapenem in the Treatment of Pseudomonas Aeruginosa Pneumonia[J].Journal of Medical Information,2018,31(09):134.[doi:10.3969/j.issn.1006-1959.2018.13.039]
[2]王春梅,闫琳琳,谷依林,等.北京西部地区某医院铜绿假单胞菌的临床分布及耐药性分析[J].医学信息,2021,34(01):145.[doi:10.3969/j.issn.1006-1959.2021.01.039]
WANG Chun-mei,YAN Lin-lin,GU Yi-lin,et al.Clinical Distribution and Drug Resistance Analysis of Pseudomonas Aeruginosa in a Hospital in Western Beijing[J].Journal of Medical Information,2021,34(09):145.[doi:10.3969/j.issn.1006-1959.2021.01.039]
[3]徐冉冉.2019-2020年我院耐碳青霉烯类铜绿假单胞菌的耐药性及临床特征分析[J].医学信息,2021,34(20):158.[doi:10.3969/j.issn.1006-1959.2021.20.042]
XU Ran-ran.Drug Resistance and Clinical Characteristics of Carbapenem-resistant Pseudomonas Aeruginosa in Our Hospital from 2019 to 2020[J].Journal of Medical Information,2021,34(09):158.[doi:10.3969/j.issn.1006-1959.2021.20.042]
[4]游六勇,罗文英.铜绿假单胞菌生物膜干预治疗的研究[J].医学信息,2022,35(06):37.[doi:10.3969/j.issn.1006-1959.2022.06.009]
YOU Liu-yong,LUO Wen-ying.Research on Pseudomonas Aeruginosa Biofilm Interventions for Governance[J].Journal of Medical Information,2022,35(09):37.[doi:10.3969/j.issn.1006-1959.2022.06.009]